Leuprolide Acetate Therapy in Luteinizing Hormone–Dependent Cushing's Syndrome

Corticotropin-independent Cushing's syndrome is usually caused by cortisol-secreting adrenal adenomas, carcinomas, or (rarely) bilateral adrenal hyperplasia. In some patients with this syndrome, the excess secretion of cortisol is caused by abnormal adrenal expression and function of receptors...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: André Lacroix, Pavel Hamet, Jean‐Marie Boutin
Médium: Artigo
Jazyk:angličtina
Vydáno: 1999
On-line přístup:https://doi.org/10.1056/nejm199911183412104
https://www.nejm.org/doi/pdf/10.1056/NEJM199911183412104?articleTools=true
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Corticotropin-independent Cushing's syndrome is usually caused by cortisol-secreting adrenal adenomas, carcinomas, or (rarely) bilateral adrenal hyperplasia. In some patients with this syndrome, the excess secretion of cortisol is caused by abnormal adrenal expression and function of receptors for various hormones, including gastric inhibitory polypeptide,1–6 vasopressin,7–9 β-adrenergic agonists,10 and interleukin-1.11 These findings suggest that diverse other hormone receptors could be implicated in other patients.12 We describe a woman with bilateral adrenal hyperplasia and corticotropin-independent Cushing's syndrome that was clinically manifested transiently during her pregnancies and became constant only after menopause. The patient's cortisol secretion was stimulated by luteinizing hormone . . .